Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

Chest

Volumn 109, Issue 4, 1996, Pages 953-956

  Kalra, Sanjay ^a   Swystun, Veronica A ^a   Bhagat, Rajesh ^a   Cockcroft, Donald W ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

airway hyperresponsiveness; asthma; bronchoprotection; inhaled corticosteroids; methacholine; salmeterol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; METHACHOLINE; PLACEBO; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029863430     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.4.953     Document Type: Article

References (16)

1. Ramage L, Lipworth BJ, Ingram CG, et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994; 88:363-68
2. 2-adrenoceptor agonist, salmeterol, on airway responsiveness in patients with mild asthma. N Engl J Med 1992; 327:1198-1203
3. Bhagat R, Kalra S, Swystun VA, et al. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 1995; 105: 1235-39
4. 2 agonist salmeterol in mild to moderate asthmatic patients. Thorax 1993; 48:1121-24
5. Cockcroft DW, Killian DN, Mellon JJA, et al. Bronchial reactivity to inhaled histamine: a method and a clinical survey. Clin Allergy 1977; 7:235-43
6. 20: comparison of linear and logarithmic interpolation. Chest 1983; 84:505-06
7. 2 agonists in asthma. N Engl J Med 1992; 327:1204-08
8. Cockcroft DW, McParland CP, Britto SA, et al. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993; 342:833-37
9. Cockcroft DW, O'Byme PM, Swystun VA, et al. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995; 96:44-9
10. Palmer JBD, Rickard KA, Thompson JR. Risks of salmeterol. N Engl J Med 1994; 331:1314
11. 2-agonists: implications for drug therapy. Drugs 1994; 47:207-22
12. Grove A, Lipworth BJ. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995; 346:201-06
13. Hui KKP, Conolly ME, Tashkin DP. Reversal of human lymphocyte β-adrenoceptor desentization by glucocorticoids. Clin Pharmacol Ther 1982; 32:566-71
14. 2-adrenoceptors: accelerated restoration of β-adrenoceptor responsiveness by prednisolone and ketotifen. J Clin Invest 1985; 76:1096-1101
15. 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med 1995; 152:1485-89
16. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336:1391-96